[HTML] nature.com

[HTML][HTML] Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response

N Gwili, SJ Jones, WA Amri, IM Carr, S Harris… - British journal of …, 2021 - nature.com
Background Breast cancer stem cells (BCSCs) are drivers of therapy-resistance, therefore
are responsible for poor survival. Molecular signatures of BCSCs from primary cancers …
被引用次数：13 相关文章

Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response

N Gwili, SJ Jones, W Al Amri, IM Carr… - British journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Breast cancer stem cells (BCSCs) are drivers of therapy-resistance, therefore
are responsible for poor survival. Molecular signatures of BCSCs from primary cancers …

Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response.

N Gwili, SJ Jones, WA Amri, IM Carr, S Harris… - British Journal of …, 2021 - europepmc.org
Background Breast cancer stem cells (BCSCs) are drivers of therapy-resistance, therefore
are responsible for poor survival. Molecular signatures of BCSCs from primary cancers …

Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response

N Gwili, SJ Jones, W Al Amri, IM Carr… - British Journal of …, 2021 - eprints.whiterose.ac.uk
Background Breast cancer stem cells (BCSCs) are drivers of therapy-resistance, therefore
are responsible for poor survival. Molecular signatures of BCSCs from primary cancers …
[HTML] nih.gov

[HTML][HTML] Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response

N Gwili, SJ Jones, W Al Amri, IM Carr… - British Journal of …, 2021 - ncbi.nlm.nih.gov
Background Breast cancer stem cells (BCSCs) are drivers of therapy-resistance, therefore
are responsible for poor survival. Molecular signatures of BCSCs from primary cancers …

Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response

N Gwili, SJ Jones, WA Amri, IM Carr… - British Journal of …, 2021 - discovery.ucl.ac.uk
BACKGROUND: Breast cancer stem cells (BCSCs) are drivers of therapy-resistance,
therefore are responsible for poor survival. Molecular signatures of BCSCs from primary …

Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response.

N Gwili, SJ Jones, W Al Amri, IM Carr, S Harris… - British journal of …, 2021 - ray.yorksj.ac.uk
Background Breast cancer stem cells (BCSCs) are drivers of therapy-resistance, therefore
are responsible for poor survival. Molecular signatures of BCSCs from primary cancers …

Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response.

N Gwili, SJ Jones, WA Amri, IM Carr, S Harris… - British Journal of …, 2021 - europepmc.org
Background Breast cancer stem cells (BCSCs) are drivers of therapy-resistance, therefore
are responsible for poor survival. Molecular signatures of BCSCs from primary cancers …
[PDF] yorksj.ac.uk

[PDF][PDF] Transcriptome profiles of stem-like cells from primary breast cancers allow identification of ITGA7 as a predictive marker of chemotherapy response

N Gwili, SJ Jones, W Al Amri, IM Carr, S Harris… - 2021 - ray.yorksj.ac.uk
BACKGROUND: Breast cancer stem cells (BCSCs) are drivers of therapy-resistance,
therefore are responsible for poor survival. Molecular signatures of BCSCs from primary …